Morris Matthew Shawn: insider trades.
Morris Matthew Shawn reported 9 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($6.6M), across 1 company.
- Transactions
- 9
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- Morris Matthew Shawn
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Privia Health Group, Inc. (PRVA) | Director | 9 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-06 | Privia Health Group, Inc. | S | 53,722 | $27.24 | 68,188 | Form 4 |
| 2026-07-06 | Privia Health Group, Inc. | M | 53,722 | $2 | 130,373 | Form 4 |
| 2026-07-02 | Privia Health Group, Inc. | M | 59,037 | $2 | 135,688 | Form 4 |
| 2026-07-02 | Privia Health Group, Inc. | S | 59,037 | $27.33 | 76,651 | Form 4 |
| 2026-07-01 | Privia Health Group, Inc. | S | 37,041 | $26.93 | 76,651 | Form 4 |
| 2026-07-01 | Privia Health Group, Inc. | S | 45,634 | $26.52 | 113,692 | Form 4 |
| 2026-07-01 | Privia Health Group, Inc. | M | 82,675 | $2 | 159,326 | Form 4 |
| 2026-06-30 | Privia Health Group, Inc. | S | 52,823 | $25.72 | 76,651 | Form 4 |
| 2026-06-30 | Privia Health Group, Inc. | M | 52,823 | $2 | 129,474 | Form 4 |
Questions
What stock did Morris Matthew Shawn buy or sell?
Morris Matthew Shawn reported 9 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($6.6M), across 1 company.
Is Morris Matthew Shawn the same person as other filers with this name?
This page covers SEC CIK 1401958 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/morris-matthew-shawn-1401958.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.